The Delhi High Court recently asked a private company to pay Rs 2 crore in damages to pharmaceutical company Pfizer for patent infringement.
Pfizer Inc. and its group companies had filed a suit in the court against Triveni Interchem Private Limited & others accusing the latter for infringing their patent(IN 218291) for the compound Palbociclib.
The private entities(Triveni entities) were found to advertise and offer for sale generic Palbociclib in API form on their own websites and on IndiaMART (e-commerce platform), without any permission or authorisation from Pfizer, Advocates Pravin Anand along with Tusha Malhotra and Richa Bhargava, who were